Macular degeneration starts with tiny yellow deposits called drusen building up beneath the retina, long before you notice any change in your vision. These deposits form when a layer of cells responsible for nourishing your light-sensing photoreceptors begins to falter, allowing lipids, proteins, and cellular waste to accumulate in a space where they don’t belong. The process is slow, often unfolding over years or decades, and understanding it can help you catch the disease early.
The Layer Where It All Begins
Behind your retina sits a single layer of cells called the retinal pigment epithelium, or RPE. Think of it as a maintenance crew for your photoreceptors: it feeds them nutrients from the blood supply underneath, recycles their waste, and absorbs stray light. Between this maintenance layer and the blood vessels below lies an ultra-thin membrane called Bruch’s membrane, only 2 to 4 micrometers thick. Its job is to act as a selective filter, letting nutrients flow up to the retina and waste products flow down to the bloodstream.
As you age, both of these structures degrade. Starting around your 40s, lipids begin accumulating inside Bruch’s membrane. By your 50s, the membrane’s ability to transport fluids has measurably declined. Research measuring molecular transport through this membrane found a 44% drop in permeability between the first and ninth decades of life. The result is a bottleneck: waste from the RPE can’t get out efficiently, and nutrients from the blood supply can’t get in.
How Drusen Form and Why They Matter
When that waste traffic jam builds, extracellular debris starts piling up between the RPE and Bruch’s membrane. The deposits, called drusen, have a core made of cholesterol-containing lipid droplets. Mineral spheres (hydroxyapatite, the same mineral in bone) precipitate onto those lipid cores, and proteins then latch onto the mineral surface. The proteins involved include amyloid-beta (the same protein implicated in Alzheimer’s disease), various fat-transport molecules, and complement proteins from the immune system.
Small drusen are common and often harmless. Nearly everyone over 50 has a few. The concern grows when drusen become larger or more numerous, because bigger deposits physically block the nutrient exchange between the blood supply and the retina. Starved of oxygen and metabolic support, the RPE cells above the drusen begin to deteriorate, and the photoreceptors they support start dying. This is the core pathology of early macular degeneration.
Oxidative Stress and Light Exposure
Your retina is one of the most metabolically active tissues in the body, and that activity generates a constant stream of unstable molecules called free radicals. Normally, your RPE cells neutralize them. But cumulative light exposure accelerates the damage. Visible light overstimulates the visual cycle in photoreceptors, producing oxidative stress that triggers programmed cell death. Animal studies have identified a threshold around 2,000 lux for one hour, below which photoreceptor loss and visual function impairment were avoided. For context, direct midday sunlight exceeds 100,000 lux, and even a bright office sits around 500 lux.
Over decades, this oxidative burden wears down the RPE’s repair capacity. The damaged cells shed more debris, which feeds the drusen cycle, and the weakened Bruch’s membrane becomes even less efficient at clearing waste. It’s a self-reinforcing loop: damage creates waste, waste blocks repair, and blocked repair accelerates damage.
Genetics and Chronic Inflammation
Not everyone with aging eyes develops macular degeneration, and genetics play a major role in who does. The single highest-impact genetic risk factor is a variant in the gene for complement factor H, a protein that normally helps shut down inflammation. The variant, called Y402H, changes a single amino acid in the protein’s structure. People carrying it have a complement system that is less effective at calming immune activity in the retina, leading to chronic, low-grade inflammation around the RPE and Bruch’s membrane.
Studies on immune cells in the retina found that this variant markedly increased the protein’s ability to block normal inflammation-resolution signals. In practical terms, the retina stays inflamed longer after routine cellular stress. That persistent inflammation damages the RPE and Bruch’s membrane faster, accelerating drusen formation even in people who might otherwise have mild age-related changes.
Smoking and Other Controllable Risk Factors
After age, smoking is the strongest modifiable risk factor. Current smokers face a two- to four-fold increase in risk compared to people who have never smoked. Over a 10-year follow-up period, current smokers had nearly four times the risk of developing late-stage disease. Even among identical twins sharing the same DNA, the twin who smoked had double the risk, confirming that the effect goes beyond genetic predisposition. Smoking intensifies oxidative stress, damages blood vessels in the choroid beneath the retina, and promotes the inflammatory signaling that drives drusen growth.
Other factors that increase your risk include obesity, high blood pressure, a diet low in leafy greens and fish, and prolonged unprotected sun exposure. Each of these either adds to oxidative burden or impairs the vascular health that the retina depends on.
Dry Versus Wet: Two Paths Forward
The process described above is dry macular degeneration, which accounts for roughly 80% to 90% of cases. In dry AMD, the damage is driven entirely by drusen accumulation, RPE loss, and the gradual thinning of the retina. Progression is typically slow, measured in years.
Wet macular degeneration occurs when the starved retina triggers the growth of new, abnormal blood vessels beneath it. These vessels are fragile and leaky, causing fluid buildup and bleeding in the macula. Wet AMD can cause rapid, severe vision loss over weeks or months. It almost always develops from pre-existing dry AMD, making early detection of the dry form critical.
What You Notice First
Early macular degeneration is notoriously silent. The drusen deposits and RPE changes that define early disease usually cause no symptoms at all. Your eye doctor can spot them during a dilated exam or with advanced imaging long before you feel anything is wrong. High-resolution imaging can now detect sub-RPE deposits that distinguish early AMD from normal aging, picking up structural markers that were previously only visible under a microscope.
When symptoms do appear, they tend to start subtly. You might notice that straight lines look slightly wavy, a distortion called metamorphopsia. Door frames, window blinds, or text on a page may appear bent or warped. Colors in the center of your vision may seem duller, or you might need brighter light to read comfortably. These changes often affect one eye first, and because the other eye compensates, they’re easy to miss.
Monitoring at Home With an Amsler Grid
An Amsler grid is a simple printed card with a grid of straight lines and a central dot, and it’s one of the most practical tools for catching early changes. To use it, hold the grid at normal reading distance (about 12 to 15 inches) while wearing your usual glasses or contacts. Cover one eye and focus on the center dot without moving your gaze. While staring at the dot, check whether all four corners of the grid are visible, and whether every line appears perfectly straight.
If you have early macular degeneration, grid lines may appear wavy or blurry. Some areas may look faded, darker, or missing entirely. Eye specialists recommend using the grid daily if you’ve been diagnosed with a retinal condition, and testing each eye separately every time. Any new distortion, even if subtle, is worth reporting promptly, particularly because it could signal a shift from dry to wet disease.